Recent News

• 03.10.2025 - Bio-Techne Begins Shipping Leo - A Next Generation High-Throughput Simple Western System
• 03.03.2025 - Bio-Techne Launches New Panel Resolving Hard-to-Decipher Carrier Screening Genes
• 02.27.2025 - Bio-Techne to Present at Investor Conferences
• 02.20.2025 - Bio-Techne Launches Expanded Menu of RNAscope Probes for Human and Mouse Transcriptome to Advance Spatial Biology
• 02.18.2025 - Bio-Techne Announces Release of GMP TcBuster Non-Viral Genome Engineering System
• 02.06.2025 - 10-Q - Quarterly report pursuant to Section 13 or 15(d)
• 02.05.2025 - Bio-Techne Releases Second Quarter Fiscal 2025 Results
• 02.05.2025 - Bio-Techne Declares Dividend
• 02.04.2025 - Bio-Techne Appoints Dr. Amy E. Herr to Board of Directors

Recent Filings

• 03.04.2025 - 8-K Current report
• 02.18.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.14.2025 - 144 Report of proposed sale of securities
• 02.07.2025 - 3 Initial statement of beneficial ownership of securities
• 02.07.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.06.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 02.05.2025 - EX-99.1 EX-99.1
• 02.05.2025 - 8-K Current report
• 02.04.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.04.2025 - 4 Statement of changes in beneficial ownership of securities